AlphaGenome 2 predicts how DNA variants affect particular cell types. Google DeepMind reports reproducing aspects of an already established inflammatory-bowel-disease finding involving ETS2 and immune cells. The aim is to narrow down what researchers should test, rather than replace laboratory experiments.